Letter

Generic substitution

Controversy over generic substitution

BMJ 2010; 341 doi: 10.1136/bmj.c3570 (Published 7 July 2010)
Cite this as: BMJ 2010;341:c3570

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Jon Emery, head1,
  2. Anne McKenzie, consumer advocate2,
  3. Caroline Bulsara, research assistant professor 3,
  4. D’Arcy Holman, head2
  1. 1School of Primary, Aboriginal and Rural Health Care, University of Western Australia, 328 Stirling Highway, Claremont, WA 6014, Australia
  2. 2School of Population Health, University of Western Australia, Clifton Street, Nedlands WA 6009, Australia
  3. 3General Practice, University of Western Australia
  1. jon.emery{at}uwa.edu.au

    Generic substitution1 has been permitted for several years in Australia but still causes problems for patients. We conducted a qualitative study of 104 Western Australian senior citizens with at least one chronic disease exploring their views and experiences of taking drugs safely. The most important and consistent theme related to generic substitution and …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular